Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Antibodies (Basel, Switzerland)|March 26, 2025
Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy?Han Sean Lee, Henry H L Wu, Arvind Ponnusamy, et al.American Journal of Nephrology|June 24, 2025
Utility of Cardiac Biomarkers (N-Terminal Pro-B-Type Natriuretic Peptide and Hs-Troponin-T) in Predicting Mortality, Cardiovascular, and Renal Outcomes in Patients with Chronic Kidney DiseaseSenthil K Vasan, Rajkumar Chinnadurai, Sharmilee Rengarajan, et al.International Journal of Hypertension|May 28, 2013
Extreme Elevations in Blood Pressure and All-Cause Mortality in a Referred CKD Population: Results from the CRISIS StudyJames Ritchie, Francesco Rainone, Darren Green, et al.Nephron. Clinical Practice|November 1, 2014
Functional status and mortality in chronic kidney disease: results from a prospective observational studyJames P Ritchie, Helen Alderson, Darren Green, et al.BMJ Open Quality|August 2, 2023
Improving outpatient clinic experience: the future of chronic kidney disease care and associated multimorbiditySaif Al-Chalabi, Helen Alderson, Natalie Garratt, et al.Glomerular Diseases|December 24, 2025
Shifting Sands or ANCA-ed in Place? The Epidemiology of ANCA-Associated Vasculitis over 2 Decades at a Large Tertiary CentreJoshua Storrar, Sawangchit Launiyomchon, Yousaf Amin, et al.BMC Nephrology|March 24, 2021
A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidismHelen Eddington, Rajkumar Chinnadurai, Helen Alderson, et al.Scientific Reports|August 13, 2017
Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney DiseaseJeffrey X Xie, Helen Alderson, James Ritchie, et al.BMC Nephrology|December 8, 2020
Safely reducing haemodialysis frequency during the COVID-19 pandemicMichelle Da Silva Lodge, Thilini Abeygunaratne, Helen Alderson, et al.Pageof 1